NASDAQ:ACHV - Achieve Life Sciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $2.94 -0.04 (-1.34 %) (As of 03/22/2019 10:38 AM ET)Previous Close$2.98Today's Range$2.9101 - $3.001652-Week Range$1.04 - $14.60Volume91,171 shsAverage Volume4.85 million shsMarket Capitalization$19.77 millionP/E Ratio-0.82Dividend YieldN/ABeta2.75 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has a license agreement with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada. Receive ACHV News and Ratings via Email Sign-up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Diagnostic substances Sub-IndustryBiotechnology SectorMedical Current SymbolNASDAQ:ACHV Previous Symbol CUSIP68230A10 CIK949858 Webachievelifesciences.com Phone604-210-2217Debt Debt-to-Equity RatioN/A Current Ratio4.75 Quick Ratio4.75Price-To-Earnings Trailing P/E Ratio-0.82 Forward P/E Ratio-2.00 P/E GrowthN/A Sales & Book Value Annual Sales$5.06 million Price / Sales3.91 Cash FlowN/A Price / Cash FlowN/A Book Value$2.35 per share Price / Book1.25Profitability EPS (Most Recent Fiscal Year)($3.61) Net Income$-12,690,000.00 Net MarginsN/A Return on Equity-96.59% Return on Assets-79.41%Miscellaneous EmployeesN/A Outstanding Shares6,720,000Market Cap$19.77 million Next Earnings Date5/8/2019 (Estimated) OptionableNot Optionable Achieve Life Sciences (NASDAQ:ACHV) Frequently Asked Questions What is Achieve Life Sciences' stock symbol? Achieve Life Sciences trades on the NASDAQ under the ticker symbol "ACHV." When did Achieve Life Sciences' stock split? How did Achieve Life Sciences' stock split work? Shares of Achieve Life Sciences reverse split on Thursday, May 24th 2018. The 1-10 reverse split was announced on Wednesday, May 23rd 2018. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 23rd 2018. An investor that had 100 shares of Achieve Life Sciences stock prior to the reverse split would have 10 shares after the split. How were Achieve Life Sciences' earnings last quarter? Achieve Life Sciences Inc (NASDAQ:ACHV) issued its earnings results on Thursday, March, 14th. The biopharmaceutical company reported ($0.55) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.37) by $0.18. View Achieve Life Sciences' Earnings History. When is Achieve Life Sciences' next earnings date? Achieve Life Sciences is scheduled to release their next quarterly earnings announcement on Wednesday, May 8th 2019. View Earnings Estimates for Achieve Life Sciences. What price target have analysts set for ACHV? 1 brokers have issued 12 month target prices for Achieve Life Sciences' shares. Their predictions range from $12.00 to $12.00. On average, they expect Achieve Life Sciences' share price to reach $12.00 in the next twelve months. This suggests a possible upside of 307.8% from the stock's current price. View Analyst Price Targets for Achieve Life Sciences. What is the consensus analysts' recommendation for Achieve Life Sciences? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Achieve Life Sciences. Has Achieve Life Sciences been receiving favorable news coverage? News headlines about ACHV stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Achieve Life Sciences earned a news impact score of 0.8 on InfoTrie's scale. They also assigned news articles about the biopharmaceutical company a news buzz of 7.0 out of 10, meaning that recent media coverage is likely to have an effect on the company's share price in the next several days. Who are some of Achieve Life Sciences' key competitors? Some companies that are related to Achieve Life Sciences include Trinity Biotech (TRIB), Celldex Therapeutics (CLDX), Riot Blockchain (RIOT), ImmuCell (ICCC), GeneNews (GNWSF), Akers Biosciences (AKER), Arca Biopharma (ABIO), Fluoropharma Medical (FPMI), BG Medicine (BGMD) and Response Genetics (RGDXQ). What other stocks do shareholders of Achieve Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Achieve Life Sciences investors own include Synergy Pharmaceuticals (SGYP), SLS International (SLS), Novavax (NVAX), Exelixis (EXEL), Inovio Pharmaceuticals (INO), Celldex Therapeutics (CLDX), Sangamo Therapeutics (SGMO), Arena Pharmaceuticals (ARNA), Verastem (VSTM) and Amicus Therapeutics (FOLD). Who are Achieve Life Sciences' key executives? Achieve Life Sciences' management team includes the folowing people: Dr. Richard A. B. Stewart, Chairman & CEO (Age 60)Dr. Anthony Clarke, Pres, Chief Scientific Officer & Director (Age 63)Mr. John A. Bencich, Exec. VP, CFO & COO (Age 42)Dr. Cindy Jacobs, Exec. VP & Chief Medical Officer (Age 61) Who are Achieve Life Sciences' major shareholders? Achieve Life Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Worth Venture Partners LLC (1.33%). View Institutional Ownership Trends for Achieve Life Sciences. Which institutional investors are buying Achieve Life Sciences stock? ACHV stock was purchased by a variety of institutional investors in the last quarter, including Worth Venture Partners LLC. View Insider Buying and Selling for Achieve Life Sciences. How do I buy shares of Achieve Life Sciences? Shares of ACHV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Achieve Life Sciences' stock price today? One share of ACHV stock can currently be purchased for approximately $2.9425. How big of a company is Achieve Life Sciences? Achieve Life Sciences has a market capitalization of $19.77 million and generates $5.06 million in revenue each year. The biopharmaceutical company earns $-12,690,000.00 in net income (profit) each year or ($3.61) on an earnings per share basis. What is Achieve Life Sciences' official website? The official website for Achieve Life Sciences is achievelifesciences.com. How can I contact Achieve Life Sciences? Achieve Life Sciences' mailing address is 1040 WEST GEORGIA STREET SUITE 1030, VANCOUVER BC, V6E 4H1. The biopharmaceutical company can be reached via phone at 604-210-2217 or via email at [email protected] MarketBeat Community Rating for Achieve Life Sciences (NASDAQ ACHV)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 222 (Vote Outperform)Underperform Votes: 202 (Vote Underperform)Total Votes: 424MarketBeat's community ratings are surveys of what our community members think about Achieve Life Sciences and other stocks. Vote "Outperform" if you believe ACHV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACHV will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: How is a Moving Average Calculated?